# Vanda Pharmaceuticals Inc.: Form 8-K, filed Jun 5, 2025

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2025-06-05
- Accepted by EDGAR: Jun 5, 2025, 16:32 ET
- Period: 2025-06-05
- Accession: 0001628280-25-029678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828025029678/vnda-20250605.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828025029678/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828025029678/vnda-20250605.htm

Filed Jun 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-029678. Last ingested by Listed: Nov 10, 2026, 17:35 ET. No prices; not investment advice.